Department of Otolaryngologyand Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Rhinology. 2010 Dec;48(4):452-6. doi: 10.4193/Rhino10.015.
To assess the efficacy of a new endonasal medial maxillectomy technique (EMM) for the treatment of inverted papilloma (IP).
A prospective series of 55 consecutive patients diagnosed with IP between March 2002 and April 2009 were entered into this study. The new surgical technique was applied to tumors arising from the anterior part of the maxillary sinus. After conventional EMM, the entire nasolacrimal duct was separated from the bony component of the nasolacrimal canal and preserved. Schirmer`s test and a visual analog scale (VAS) score were used to assess the lacrimal duct function after surgery.
Ten of the 55 patients underwent the new surgical procedure. All patients were categorized with stage T3 or T4 tumors. No patients suffered tumor recurrence. There was no difference in lacrimal duct function between the diseased side and healthy side of the nasolacrimal duct. The mean VAS score was 2.8/100.
This new surgical technique preserves the whole length of the nasolacrimal unit. It also offers several advantages including good visualization, nasolacrimal function after surgery and fewer adverse effects such as facial numbness and epiphora.
评估一种新的经鼻内内侧上颌窦切开术(EMM)治疗内翻性乳头状瘤(IP)的疗效。
前瞻性系列研究纳入了 2002 年 3 月至 2009 年 4 月期间诊断为 IP 的 55 例连续患者。该新手术技术应用于起源于上颌窦前份的肿瘤。在常规 EMM 后,将整个鼻泪管从鼻泪管的骨成分中分离出来并保留。Schirmer 测试和视觉模拟评分(VAS)用于评估手术后的泪道功能。
55 例患者中有 10 例接受了新的手术。所有患者均归类为 T3 或 T4 期肿瘤。无患者发生肿瘤复发。鼻泪管的患病侧和健康侧的泪道功能无差异。平均 VAS 评分为 2.8/100。
这种新的手术技术保留了整个鼻泪管单位。它还具有许多优点,包括良好的可视化、术后鼻泪管功能以及较少的不良影响,如面部麻木和溢泪。